Filter: All News Events
13.05.2020

NEOVII Partners with Tel Aviv University to Develop Novel COVID-19 Vaccine

31.05.2019

Neovii & Mundipharma Confirm In-licensing Agreement

15.09.2017

Neovii Pharmaceuticals AG announces new CEO

26.07.2017

Neovii completes marketing authorisation withdrawal of Removab® in the European Union

14.09.2016

Neovii Pharmaceuticals AG licenses worldwide (excluding U.S. & Japan) developmental and commercialization rights for ARCALYST® (rilonacept) from Regeneron for the treatment of periodic fever syndromes

14.01.2016

European study in patients with acute leukemia shows the inclusion of Grafalon® (anti T-lymphocyte immunoglobulin) in a conditioning regimen before stem cell transplantation from HLA-identical siblings results in a significantly lower incidence of chronic GvHD.